Ulcerative colitis: open trials in Czechia

19 open trials have a site in Czechia. Registry data; only the trial team decides who can take part.

2023-507853-13-00
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly & Co.
SurGal Clinic s.r.o., Brno-Sever · Vojenska Nemocnice Brno, Brno-Zidenice · Nemocnice Slany, Slaný · Krajska Nemocnice T Bati a.s., Zlin
Registry updated 2026-11-05
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
SurGal Clinic, Brno · Gastroenterologie, Hradec Králové · EndoArt, Ostrava · ResTrial GastroEndo s.r.o, Prague · ISCARE klinické centrum, Prague · Masarykova nemocnice v Usti nad Labem, Ústí nad Labem
Registry updated 2026-11-04
NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
Hepato-Gastroenterologie HK, Hradec Králové · Nemocnice Pardubickeho kraje, Pardubice · Clinoxus, Prague · MEDICON, Prague · ISCARE klinické centrum, Prague · Nemocnice Slany, Slaný · Nemocnice AGEL Šternberk, Sternberk · Clinical Trials Service s.r.o., Uherské Hradiště · Gastro-nell, Vsetín
Registry updated 2026-11-04
NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Vojenska Nemocnice Brno, Brno-Zidenice · Hepato-Gastroenterologie HK, s.r.o., Hradec Králové
Registry updated 2026-11-03
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
SurGal Clinic s.r.o., Brno-Sever · Nemocnice České Budějovice, a.s., České Budějovice · Gastroenterologie s.r.o., Hradec Králové · Hepato-Gastroenterologie HK, s.r.o., Hradec Králové · Oblastni nemocnice Kladno a.s. nemocnice Stredoceskeho kraje, Kladno · Fakultni nemocnice Ostrava, Ostrava · ISCARE a.s., Prague · Fakultni Thomayerova nemocnice, Prague · Institute for Clinical and Experimental Medicine, Prague
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Fakultni nemocnice Brno, Brno · SurGal Clinic s.r.o., Brno-Sever · Vojenska Nemocnice Brno, Brno-Zidenice · GASTRO JeKa s.r.o., Klatovy IV · CCR Ostrava s.r.o., Moravska Ostrava A Privoz · Nemocnice Pardubickeho kraje a.s., Pardubice · Fakultni Nemocnice Motol a Homolka, Prague
Registry updated 2026-11-03
NCT06979336
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Trial Treatment · Phase 2 · Genentech, Inc.
PreventaMed, s.r.o., Olomouc
Registry updated 2026-10-27
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Fakultni nemocnice Brno, Brno · SurGal Clinic s.r.o., Brno-Sever · Vojenska Nemocnice Brno, Brno-Zidenice · GASTRO JeKa s.r.o., Klatovy IV · CCR Ostrava s.r.o., Moravska Ostrava A Privoz · Nemocnice Pardubickeho kraje a.s., Pardubice · Fakultni Nemocnice Motol a Homolka, Prague
Registry updated 2026-10-27
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Brno · Hradec Králové
Registry updated 2026-10-23
2025-524404-29-00
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Trial Treatment · Phase 2 · Eli Lilly & Co.
Hepato-Gastroenterologie HK, s.r.o., Hradec Králové · Nemocnice Pardubickeho kraje a.s., Pardubice · ISCARE a.s., Prague · Clinoxus s.r.o., Prague 4 · MEDICON a.s., Prague 4 · Nemocnice Slany, Slaný · AGEL Stredomoravska nemocnicni a.s., Sternberk · Clinical Trials Service s.r.o., Uherské Hradiště · GASTRO NELL s.r.o., Vsetin
Registry updated 2026-10-21
NCT07296315
Confirmatory Clinical Study in Active Ulcerative Colitis
Trial Treatment · Phase 2 · MRM Health NV
Vojenska Nemocnice Brno, Brno-Zidenice · Hepato-Gastroenterologie HK, s.r.o., Hradec Králové · Fakultni Thomayerova nemocnice, Prague · Endohope klinika s.r.o., Prague · Nemocnice Slany, Slaný
Registry updated 2026-10-21
NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Palisade Bio
Site CZ-002, Brno · Site CZ-005, Brno · Site CZ-008, Havířov · Site CZ-006, Hradec Králové · Site CZ-007, Prague · Site CZ-004, Slaný
Registry updated 2026-10-21
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Hradec Králové
Registry updated 2026-10-16
NCT06636656
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Trial Treatment · Phase 2 · Boehringer Ingelheim
Hepato-Gastroenterologie HK, s.r.o., Hradec Králové · ISCARE a.s., Prague
Registry updated 2026-08-21
2024-520201-39-00
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics Inc.
Hepato-Gastroenterologie HK, s.r.o., Hradec Králové
Registry updated 2026-07-31
2025-522001-38-00
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Trial Treatment · Phase 2 · Mirador Therapeutics Inc.
SurGal Clinic s.r.o., Brno-Sever · Vojenska Nemocnice Brno, Brno-Zidenice · Nemocnice Prachatice a.s., Prachatice
Registry updated 2026-07-20
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Fakultni nemocnice Brno, Brno · SurGal Clinic s.r.o., Brno-Sever · Vojenska Nemocnice Brno, Brno-Zidenice · Nemocnice České Budějovice, a.s., České Budějovice · Hepato-Gastroenterologie HK, s.r.o., Hradec Králové · Fakultni nemocnice Ostrava, Ostrava · Gastromedic s.r.o, Pardubice · Endohope klinika s.r.o., Prague · Fakultni nemocnice Kralovske Vinohrady, Prague · Axon Clinical s.r.o., Prague 5 · EndoArt s.r.o., Slezska Ostrava · Krajska zdravotni a.s., Usti Nad Labem
Registry updated 2026-05-22
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Fakultni nemocnice Kralovske Vinohrady, Prague · Fakultni Thomayerova nemocnice, Prague
Registry updated 2026-05-07
NCT06850727
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics, Inc.
CHUM - Pavillon R, Polička
Registry updated 2026-02-11

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error